Paul Pfeffer

Respiratory Dr with interest in asthma and airways immunology, personalised medicine and effects of the environment. Also coffee, comedies and music.

[Manali Mukherjee @DrMMukherjee]

#newpublication Alert ‼️
EGPA, benralizumab reduced airway autoimmune responses (spANCA and IL-17A) and eosinophilic inflammation, while mepolizumab was linked to persistent or increased autoimmune activity https://t.co/GiAp32BTz0 check out the mechanistic substudy of #Mandara Trial #MukherjeeLab
Shout out to PhD student Nadia Suray Tan for the crucial work @machealthsci @ResearchStJoes @ERSpublications

[@SBHRLHRespEd @SbhRlhRespEd]

This week's question was written by Prof Paul Pfeffer, who is an Asthma specialist at Bart's Hospital.

Answers to come Friday!

[@SBHRLHRespEd @SbhRlhRespEd]

New respiratory education account

Sharing Respiratory SCE-style questions, exam tips, and regular updates on UK courses, key papers, podcasts and exam news.

Follow along and learn together.

#MedTwitter
#Mededucation
@LancetRespirMed
@BTOGORG
@BTSrespiratory

[ERS publications @ERSpublications]

ERJOR: Severe asthma biologics are effective in a broad range of patients, including those not meeting the inclusion/exclusion criteria for phase 3 RCTs, although noninferiority could not be shown for those RCT-ineligible by poor medication adherence https://t.co/jAscfptOze

[ERS publications @ERSpublications]

Indoor and outdoor air pollution come from many sources and can worsen asthma control @DoctorPfeffer @dr_abi_w https://t.co/IOAD4PhoTw

[Paul Pfeffer @DoctorPfeff]

@ImogenSkene And to provide patient-friendly education on why we might advise changes to inhaled therapy. @NHSBartsHealth @NELHCP https://t.co/WnvJY0cQnB

[Paul Pfeffer @DoctorPfeff]

Great to see our new paper out showing the cardiovascular dangers from high SABA blue reliever use. And our recent research on implementing SABA-free management. @QMULBartsTheLon @opri_sg https://t.co/t0HLn3HWen

[Paul Pfeffer @DoctorPfeff]

Important to understand the health beliefs of patients towards changes to their asthma medication, including in emergency settings @ImogenSkene https://t.co/9CfrXlWKWZ https://t.co/WZlhiEPhc6

[Hitasha Rupani @tasha_rupani]

A great infographic @asthma management. @BTSrespiratory @asthmalunguk

[Imogen Skene @ImogenSkene]

Is an Emergency Department presentation at opportunity to tackle SABA overuse and improve asthma control?

Our new paper explores patient beliefs, and attitudes to inhaler changes @DoctorPfeff

https://t.co/ONZlCRlzCI

#Asthma #EmergencyMedicine

[Imogen Skene @ImogenSkene]

We've developed a short video for people with asthma who may be offered a new type of inhaler therapy called MART or AIR.
🎥 Watch the video here: https://t.co/tC7WpFph9V
✅ Right medication
✅ Right way
✅ Right support
#asthma @DoctorPfeff

[Hitasha Rupani @tasha_rupani]

The BTS/NICE/SIGN asthma guideline @BTSrespiratory

Read the editorial I’ve written-
https://t.co/STTJtGNdif

[Paul Pfeffer @DoctorPfeff]

@ImogenSkene Can we do better than just prescribing SABA and OCS for patients attending A&E with asthma attacks? Yes! But first we have to consider barriers and facilitators to proving better long-term asthma management in Emergency Departments. It’s more than just updated guidelines.

[National Institute for Health and Care Research @NIHRresearch]

NIHR funded research has developed a mobile phone app to support people recovering from long Covid at home 📱

Read the #MakingaDifference story ➡️ https://t.co/DIKGqtT05W

[Hitasha Rupani @tasha_rupani]

It’s published! An international consensus on the us of #asthma #biologics in #pregnancy

https://t.co/Ryz5AFkH8f

[Imperial School of Public Health @ImperialSPH]

Congratulations to Professor Frank Kelly OBE who has been recognised in the 2025 New Years Honours list for services to air pollution research and to human health.

[Ian Jarrold @IanJarroldALUK]

Well said @Nickmaskell1!

Supporting the growth of a thriving community of lung researchers is imperative if we're going to transform lung health!

@asthmalunguk @aluk_research

[David Baddiel @Baddiel]

Wasn't expecting Del Amitri to get it so right #Melbourne

[christabelle @Christab3lleMin]

#BTSWinter2024 Fantastic opening of Severe asthma biologic session by @DoctorPfeff sharing registry real world data of patients who did not show association of inferior biologic response despite being ineligible for clinical trials.